125 related articles for article (PubMed ID: 37098307)
1. Design, synthesis, and anti-inflammatory activity characterization of novel brain-permeable HDAC6 inhibitors.
Liu G; Mondal P; Sang N; Li Z; Ding W; Yang L; Liu Y; Birar VC; Gomm A; Tanzi RE; Zhang C; Shen S; Wang C; Lu X; Bai P
Eur J Med Chem; 2023 Jun; 254():115327. PubMed ID: 37098307
[TBL] [Abstract][Full Text] [Related]
2. Groebke Blackburn Bienaymé-mediated multi-component synthesis of selective HDAC6 inhibitors with anti-inflammatory properties.
Kraft FB; Enns J; Honin I; Engelhardt J; Schöler A; Smith ST; Meiler J; Schäker-Hübner L; Weindl G; Hansen FK
Bioorg Chem; 2024 Feb; 143():107072. PubMed ID: 38185013
[TBL] [Abstract][Full Text] [Related]
3. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
Negmeldin AT; Knoff JR; Pflum MKH
Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
[TBL] [Abstract][Full Text] [Related]
4. Preclinical Evaluation of an
Tago T; Toyohara J; Ishii K
ACS Chem Neurosci; 2021 Feb; 12(4):746-755. PubMed ID: 33502174
[TBL] [Abstract][Full Text] [Related]
5. Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects.
Vishwakarma S; Iyer LR; Muley M; Singh PK; Shastry A; Saxena A; Kulathingal J; Vijaykanth G; Raghul J; Rajesh N; Rathinasamy S; Kachhadia V; Kilambi N; Rajgopal S; Balasubramanian G; Narayanan S
Int Immunopharmacol; 2013 May; 16(1):72-8. PubMed ID: 23541634
[TBL] [Abstract][Full Text] [Related]
6. PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia.
Gawel JM; Shouksmith AE; Raouf YS; Nawar N; Toutah K; Bukhari S; Manaswiyoungkul P; Olaoye OO; Israelian J; Radu TB; Cabral AD; Sina D; Sedighi A; de Araujo ED; Gunning PT
Eur J Med Chem; 2020 Sep; 201():112411. PubMed ID: 32615502
[TBL] [Abstract][Full Text] [Related]
7. HDAC6 inhibition blocks inflammatory signaling and caspase-1 activation in LPS-induced acute lung injury.
Liu L; Zhou X; Shetty S; Hou G; Wang Q; Fu J
Toxicol Appl Pharmacol; 2019 May; 370():178-183. PubMed ID: 30910594
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of HDAC6 inhibitors targeting L1 loop and serine 531 residue.
Jha S; Kim JH; Kim M; Nguyen AH; Ali KH; Gupta SK; Park SY; Ha E; Seo YH
Eur J Med Chem; 2024 Feb; 265():116057. PubMed ID: 38142511
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of brain penetrant benzazepine-based histone deacetylase 6 inhibitors for alleviating stroke-induced brain infarction.
Guo Z; Zhang Z; Zhang Y; Wang G; Huang Z; Zhang Q; Li J
Eur J Med Chem; 2021 Jun; 218():113383. PubMed ID: 33799069
[TBL] [Abstract][Full Text] [Related]
10. Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality.
Chen Y; Sun J; Tong H; Wang J; Cao R; Xu H; Chen L; Morisseau C; Zhang M; Shi Y; Han C; Zhuang J; Jing Y; Liu Z; Hammock BD; Chen G
J Med Chem; 2024 Feb; 67(3):2095-2117. PubMed ID: 38236416
[TBL] [Abstract][Full Text] [Related]
11. Computer-aided identification of new histone deacetylase 6 selective inhibitor with anti-sepsis activity.
Yoo J; Kim SJ; Son D; Seo H; Baek SY; Maeng CY; Lee C; Kim IS; Jung YH; Lee SM; Park HJ
Eur J Med Chem; 2016 Jun; 116():126-135. PubMed ID: 27060764
[TBL] [Abstract][Full Text] [Related]
12. Difluoromethyl-1,3,4-oxadiazoles are slow-binding substrate analog inhibitors of histone deacetylase 6 with unprecedented isotype selectivity.
Cellupica E; Caprini G; Cordella P; Cukier C; Fossati G; Marchini M; Rocchio I; Sandrone G; Vanoni MA; Vergani B; Źrubek K; Stevenazzi A; Steinkühler C
J Biol Chem; 2023 Jan; 299(1):102800. PubMed ID: 36528061
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant-like properties of novel HDAC6-selective inhibitors with improved brain bioavailability.
Jochems J; Boulden J; Lee BG; Blendy JA; Jarpe M; Mazitschek R; Van Duzer JH; Jones S; Berton O
Neuropsychopharmacology; 2014 Jan; 39(2):389-400. PubMed ID: 23954848
[TBL] [Abstract][Full Text] [Related]
14. First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation.
Yue K; Sun S; Jia G; Qin M; Hou X; Chou CJ; Huang C; Li X
J Med Chem; 2022 Sep; 65(18):12140-12162. PubMed ID: 36073117
[TBL] [Abstract][Full Text] [Related]
15. The structural requirements of histone deacetylase inhibitors: SAHA analogs modified at the C5 position display dual HDAC6/8 selectivity.
Negmeldin AT; Pflum MKH
Bioorg Med Chem Lett; 2017 Aug; 27(15):3254-3258. PubMed ID: 28648461
[TBL] [Abstract][Full Text] [Related]
16. Discovery of the First Irreversible HDAC6 Isoform Selective Inhibitor with Potent Anti-Multiple Myeloma Activity.
Liu F; Liu C; Chai Q; Zhao C; Meng H; Xue X; Yao TP; Zhang Y
J Med Chem; 2023 Jul; 66(14):10080-10091. PubMed ID: 37463038
[TBL] [Abstract][Full Text] [Related]
17. A novel class of anthraquinone-based HDAC6 inhibitors.
Song Y; Lim J; Seo YH
Eur J Med Chem; 2019 Feb; 164():263-272. PubMed ID: 30597327
[TBL] [Abstract][Full Text] [Related]
18. Image-guided synthesis reveals potent blood-brain barrier permeable histone deacetylase inhibitors.
Seo YJ; Kang Y; Muench L; Reid A; Caesar S; Jean L; Wagner F; Holson E; Haggarty SJ; Weiss P; King P; Carter P; Volkow ND; Fowler JS; Hooker JM; Kim SW
ACS Chem Neurosci; 2014 Jul; 5(7):588-96. PubMed ID: 24780082
[TBL] [Abstract][Full Text] [Related]
19. Novel pyrrolo[2,1-c][1,4]benzodiazepine-3,11-dione (PBD) derivatives as selective HDAC6 inhibitors to suppress tumor metastasis and invasion in vitro and in vivo.
Li Y; Quan J; Song H; Li D; Ma E; Wang Y; Ma C
Bioorg Chem; 2021 Sep; 114():105081. PubMed ID: 34153811
[TBL] [Abstract][Full Text] [Related]
20. Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors.
Leonhardt M; Sellmer A; Krämer OH; Dove S; Elz S; Kraus B; Beyer M; Mahboobi S
Eur J Med Chem; 2018 May; 152():329-357. PubMed ID: 29738953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
